European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The European Association for the Study of Diabetes (EASD) has developed a Standard Operating Procedure (SOP) for the development of clinical practice guidelines, ensuring adherence to rigorous methodological standards based on the principles of the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. Key components include a transparent process for managing conflicts of interest, the incorporation of multidisciplinary panels including individuals with lived experience of diabetes, an evidence synthesis based on comprehensive systematic reviews, and an explicit peer review process. This SOP delineates the roles and responsibilities of the main structures involved, including the Guidelines Oversight Committee, Guideline Development Panels, and Evidence Synthesis Teams. Additionally, the SOP describes the main stages in guideline development, namely scoping of the guideline topic, evidence synthesis, development of Evidence-to-Decision frameworks for the formulation of clear, patient-centred recommendations, writing of the guideline document and the review process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The simulated cases focused on T2DM and were constructed in accordance with the American Diabetes Association’s (ADA) 2025 Standards of Care and the European Association for the Study of Diabetes (EASD) 2023 Guidelines on Patient Communication, ensuring clinical and pedagogical relevance (American Diabetes Association Professional Practice Committee, 2025; Karagiannis et al., 2025).”
From DIALOGUE: A Generative AI-Based Pre–Post Simulation Study to Enhance Diagnostic Communication in Medical Students Through Virtual Type 2 Diabetes Scenarios (2025) · cites this paper as Karagiannis et al., 2025
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787 · cited 1×
“Suitable tools should be used to assess the risk of bias in eligible studies, such as Cochrane’s RoB 2 for RCTs, ROBINS-I for non-RCTs, QUADAS-2 for diagnostic accuracy studies, and QUIPS for prognostic studies [28–31].”
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · cited 5×
“The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) Working Group has created and continually refines comprehensive methodological guidance for producing guidelines that meet the high standards set by the NAM and GIN [5–7].”
InfluentialShea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636 · cited 1×
“However, when considering the use of an existing systematic review, the GDP, guided by its methodologists, must ascertain that the review is of adequate quality, as assessed by relevant tools such as AMSTAR 2 or ROBIS [26, 27].”
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · cited 6×
“The GRADE approach encapsulates Table 2 Levels of certainty of evidence according to the GRADE framework Adapted from GRADE guideline 3 [7] with permission”
InfluentialNorderyd, O. M., Koch, G., Papias, A., Köhler, A. A., Helkimo, A. N., Brahm, C., Lindmark, U., Lindfors, N., Mattsson, A., Rolander, B., et al. (2015) · PubMed · Cited by 3,584
Assessing Bias in Studies of Prognostic Factors
Hayden, J. A., van der Windt, D. A., Cartwright, J. L., Côté, P., & Bombardier, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00009 · Cited by 3,287 · cited 1×
“Suitable tools should be used to assess the risk of bias in eligible studies, such as Cochrane’s RoB 2 for RCTs, ROBINS-I for non-RCTs, QUADAS-2 for diagnostic accuracy studies, and QUIPS for prognostic studies [28–31].”
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081 · cited 5×
“For any such collaborative effort to proceed, it is essential that the guideline development adheres to the core trustworthiness standards set by the NAM and GIN, as well as meeting the key domains outlined in the AGREE II instrument [1, 2, 16].”
InfluentialROBIS: A new tool to assess risk of bias in systematic reviews was developed
Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911 · cited 2×
“Similarly, the key outcomes for each clinical question are identified through a prioritisation process [6].”
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416 · cited 6×
“These may include the balance between desirable and undesirable outcomes, the values and preferences of people affected by the condition of interest, cost-effectiveness, the impact on health equity, acceptability and feasibility [19, 21, 35].”
InfluentialAndrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315 · cited 4×
“The third stage focuses on the formulation of clinical practice recommendations by the GDP, employing the GRADE EtD frameworks [19, 21, 35].”
InfluentialGuidelines International Network: Toward International Standards for Clinical Practice Guidelines
Qaseem, A., Forland, F., Macbeth, F., Ollenschläger, G., Phillips, S., van der Wees, P., & for the Board of Trustees of the Guidelines International Network* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00009 · Cited by 902 · cited 2×
“For any such collaborative effort to proceed, it is essential that the guideline development adheres to the core trustworthiness standards set by the NAM and GIN, as well as meeting the key domains outlined in the AGREE II instrument [1, 2, 16].”
GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
Guyatt, G. H., Oxman, A. D., Santesso, N., Helfand, M., Vist, G., Kunz, R., Brozek, J., Norris, S., Meerpohl, J., Djulbegovic, B., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.012 · Cited by 836 · cited 2×
“For each clinical question, a maximum of seven outcomes (including both benefits and harms) should be chosen [25].”
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
Guyatt, G. H., Thorlund, K., Oxman, A. D., Walter, S. D., Patrick, D., Furukawa, T. A., Johnston, B. C., Karanicolas, P., Akl, E. A., Vist, G., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.08.001 · Cited by 772 · cited 1×
“Each PICOT question should be accompanied by one GRADE evidence profile and a summary of findings table [25, 34].”
Guyatt, G., Oxman, A. D., Sultan, S., Brozek, J., Glasziou, P., Alonso-Coello, P., Atkins, D., Kunz, R., Montori, V., Jaeschke, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.006 · Cited by 762 · cited 3×
“Overall certainty of evidence can range from high to moderate, low or very low and is usually dictated by the lowest certainty of evidence assigned to any of the critical outcomes [20].”
Schandelmaier, S., Briel, M., Varadhan, R., Schmid, C. H., Devasenapathy, N., Hayward, R. A., Gagnier, J., Borenstein, M., van der Heijden, G. J. M. G., Dahabreh, I. J., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200077 · Cited by 749 · cited 1×
“In this step, it is important to perform clinically relevant subgroup analyses, which ideally should be predefined in the protocol, and interpret their findings through robust methodology [32, 33].”
A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement
Chen, Y., Yang, K., Marušić, A., Qaseem, A., Meerpohl, J. J., Flottorp, S., Akl, E. A., Schünemann, H. J., Chan, E. S. Y., Falck-Ytter, Y., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1565 · Cited by 665
Schünemann, H. J., Wiercioch, W., Brozek, J., Etxeandia-Ikobaltzeta, I., Mustafa, R. A., Manja, V., Brignardello-Petersen, R., Neumann, I., Falavigna, M., Alhazzani, W., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.09.009 · Cited by 645 · cited 2×
“…potential partner organisations’ websites and e-learning platforms; social media; and graphical abstracts, lay language summaries, decision aids and non-English language translations and ‘GRADE-Adolopment’ (adoption, adaptation and, as needed, de novo development of recommendations) versions [42].”
AGREE II: Advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.001 · Cited by 563
Living systematic reviews: 4. Living guideline recommendations.
Akl, E. A., Meerpohl, J. J., Elliott, J., Kahale, L. A., Schünemann, H. J., Agoritsas, T., Hilton, J., Perron, C., Akl, E., Hodder, R., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.08.009 · Cited by 328 · cited 2×
“The EASD aspires to evolve its guidelines into ‘living documents’, with individual recommendations (‘living rec-ommendations’) updated in real-time, rather than on a 3 year basis, as pertinent new data become available [43].”
Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group
Guyatt, G. H., Alonso-Coello, P., Schünemann, H. J., Djulbegovic, B., Nothacker, M., Lange, S., Murad, M. H., & Akl, E. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.07.006 · Cited by 243 · cited 1×
“A GPS is warranted only if it meets these criteria: the recommendation is necessary for safe, effective healthcare; the expected net benefit is substantial and clear; and conducting a formal evidence synthesis would be an inefficient use of resources due to high opportunity costs [37, 38].”
Guideline panels should not GRADE good practice statements
Guyatt, G. H., Schünemann, H. J., Djulbegovic, B., & Akl, E. A. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.011 · Cited by 201 · cited 1×
“A GPS is warranted only if it meets these criteria: the recommendation is necessary for safe, effective healthcare; the expected net benefit is substantial and clear; and conducting a formal evidence synthesis would be an inefficient use of resources due to high opportunity costs [37, 38].”
Distinguishing opinion from evidence in guidelines
Schünemann, H. J., Zhang, Y., & Oxman, A. D. (2019) · BMJ · doi:10.1136/bmj.l4606 · Cited by 106 · cited 1×
“As such, these recommendations are primarily based on the collective expertise and clinical judgement of the GDP members in the absence of robust evidence [39, 40].”
Qaseem, A., Kansagara, D., Lin, J. S., Mustafa, R. A., Wilt, T. J., & for the Clinical Guidelines Committee of the American College of Physicians* (2019) · Annals of Internal Medicine · doi:10.7326/m18-3290 · Cited by 90 · cited 2×
“WHO and an expanding roster of international health associations have adopted the GRADE methodology in their own guideline development procedures [4, 8–14].”
Mustafa, R. A., Cuello‐García, C. A., Bhatt, M., Riva, J. J., Vesely, S. K., Wiercioch, W., Nieuwlaat, R., Patel, P., Hanson, S. J., Newall, F. H., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.02.026 · Cited by 64 · cited 1×
“As such, these recommendations are primarily based on the collective expertise and clinical judgement of the GDP members in the absence of robust evidence [39, 40].”
Steiner, T., Dichgans, M., Norrving, B. G., Aamodt, A. H., Berge, E., Christensen, H., Fuentes, B., Khatri, P., Korompoki, E., Martí‐Fábregas, J., et al. (2021) · European Stroke Journal · doi:10.1177/23969873211024143 · Cited by 38
Reporting Conflicts of Interest and Funding in Health Care Guidelines: The RIGHT-COI&F Checklist
Xun, Y., Estill, J. A. M., Khabsa, J., Flórez, I. D., Guyatt, G. H., Norris, S. L., Lee, M. S., Ozaki, A., Qaseem, A., Schünemann, H. J., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3274 · Cited by 27 · cited 1×
“…outlined in the extension of the Reporting Items for practice Guidelines in HealThcare (RIGHT) statement for the reporting of COIs in policy documents of guideline organisations, including defining COIs, detailing the dec-laration process and specifying how COIs are assessed and managed [24].”
Standardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines
Piggott, T., Baldeh, T., Dietl, B., Wiercioch, W., Nieuwlaat, R., Santesso, N. A., Alonso‐Coello, P., & Schünemann, H. J. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.01.004 · Cited by 26 · cited 7×
“These may include the balance between desirable and undesirable outcomes, the values and preferences of people affected by the condition of interest, cost-effectiveness, the impact on health equity, acceptability and feasibility [19, 21, 35].”
InfluentialEuropean Respiratory Society clinical practice guidelines: methodological guidance
Nagavci, B., Tonia, T., Roche, N., Genton, C., Vaccaro, V., Humbert, M. J. C., Brightling, C. E., Cordeiro, C. R., & Bush, A. (2022) · ERJ Open Research · doi:10.1183/23120541.00655-2021 · Cited by 19
A memorandum of understanding has facilitated guideline development involving collaborating groups
Alam, M., Getchius, T. S. D., Schünemann, H. J., Amer, Y. S., Bak, A., Fatheree, L. A., Ginex, P., Jakhmola, P., Marsden, G. L., McFarlane, E., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.12.022 · Cited by 17
Karagiannis, T., Τσάπας, Α., Bekiari, E., Toulis, K. A., & Nauck, M. A. (2024) · Diabetes Care · doi:10.2337/dc23-0925 · Cited by 17
Self-citationDevelopment of an international glossary for clinical guidelines collaboration
Christensen, R. E., Yi, M. D., Kang, B. Y., Ibrahim, S. A., Anvery, N., Dirr, M. A., Adams, S., Amer, Y. S., Bisdorff, A., Bradfield, L., et al. (2023) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2023.03.026 · Cited by 14 · cited 1×
“Such a glossary can facilitate alignment, reduce ambiguities and promote coherent interpretation of key terms [44].”
Enhancing the Trustworthiness of the Endocrine Society’s Clinical Practice Guidelines
McCartney, C. R., Corrigan, M. D., Drake, M. T., Fuleihan, G. E., Korytkowski, M. T., Lash, R. W., Lieb, D. C., McCall, A. L., Muniyappa, R., Piggott, T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac290 · Cited by 13
Research works printed but not linked: 1
- World Health Organization (2014) Decision-making for guideline development at WHO. In: WHO (ed.) WHO handbook for guideline development, 2nd edn. WHO Press, Geneve, pp 201–214
Cited by
Suárez-García, R. X., Chavez-Castañeda, Q., Orrico-Pérez, R., Valencia-Marin, S., Castañeda-Ramírez, A. E., Quiñones-Lara, E., Ramos-Cortés, C. A., Gaytán-Gómez, A. M., Cortés-Rodríguez, J., Jarquín-Ramírez, J., et al. (2025) · European Journal of Investigation in Health, Psychology and Education · doi:10.3390/ejihpe15080152 · Cited by 18
“…Diabetes Association’s (ADA) 2025 Standards of Care and the European Association for the Study of Diabetes (EASD) 2023 Guidelines on Patient Communication, ensuring clinical and pedagogical relevance (American Diabetes Association Professional Practice Committee, 2025; Karagiannis et al., 2025).”
Speight, J., Hermanns, N., Jensen, W., Kanc, K., Karagiannis, T., Law, M., Mocan, A., Rutters, F., Sturt, J. A., Zaccardi, F., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06840-0 · Cited by 15
“This is the first guideline developed under the new EASD guideline development process, according to its Standard Operating Procedure [46] and internationally recognised principles for trustworthy guidelines [47–50].”
InfluentialSelf-citationWanner, C., Cosentino, F., Barnard-Kelly, K. D., Battelino, T., Blüher, M., Boll, H. N., Brosius, F. C., Busetto, L., Ceriello, A., Gavin, J. R., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03098-z · Cited by 4
Schipper, S. B. J., Karagiannis, T., Zaccardi, F., Remmelzwaal, S., Blom, M. T., Dagan, N., Schoonmade, L. J., Langendam, M. W., Mb, J., Jensen, W., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06789-0 · Cited by 4
“The EASD has recognised the importance of diabetes distress and has commissioned an evidence-based clinical guideline to enable healthcare professionals to optimise their support of people living with diabetes and diabetes distress [10].”
Self-citationHolt, R. I. G., Τσάπας, Α., Meireles, M., Mulder, H., & Mathieu, C. (2025) · Diabetologia · doi:10.1007/s00125-025-06378-7 · Cited by 3
Self-citation
Metadata
- Authors
- Karagiannis, T., Advani, A., Davies, M. J., Del Prato, S., Dinneen, S. F., Kuss, O., Lorenzoni, V., Mathieu, C., Mauricio, D., Tankova, T., Zaccardi, F., Holt, R. I. G., Tsapas, A., & on behalf of the EASD Guidelines Oversight Committee
- Affiliations
- Aristotle University of Thessaloniki (GR)
- St. Michael's Hospital (CA)
- University of Leicester (GB)
- Deutsches Diabetes-Zentrum e.V. (DE)
- Scuola Superiore Sant'Anna (IT)
- Universitair Ziekenhuis Leuven (BE)
- Medical University of Sofia (BG)
- University Hospital Southampton NHS Foundation Trust (GB)
- Corresponding author
- Karagiannis, Thomas
- ORCID
- Venue
- Diabetologia
- Published
- 2025-05-26
- Volume
- 68
- Issue
- 8
- Pages
- 1600-1615
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC12245959
- OpenAlex
- W4410885215
- Cited by
- 14
- References
- 37
- Citations by year
- 2026: 7 · 2025: 7
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc-nd)
- Lirias (KU Leuven) (submittedVersion, cc-by-nc-nd)
- CINECA IRIS Institutional Research Information System (Sant'Anna School of Advanced Studies) (submittedVersion, public-domain)
- Funders
- McMaster University
- Università degli Studi di Firenze
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Health Sciences › Health Professions › General Health Professions › Health Sciences Research and Education
- Keywords
- clinical guideline development, standard operating procedures, GRADE framework, conflicts of interest, lived experience of diabetes, systematic reviews, evidence synthesis, peer review, evidence-to-decision framework
- MeSH terms
- Diabetes Mellitus, Europe, Humans, Societies, Medical, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.